Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome
<b>Background:</b> Hypertriglyceridemia has serious health risks such as cardiovascular disease, type 2 diabetes mellitus, nephropathy, and others. Fenofibrate is an effective hypolipidemic drug, but its benefits for ameliorating disorders associated with hypertriglyceridemia failed to b...
Saved in:
| Main Authors: | Jan Soukop, Ludmila Kazdová, Martina Hüttl, Hana Malínská, Irena Marková, Olena Oliyarnyk, Denisa Miklánková, Soňa Gurská, Zuzana Rácová, Martin Poruba, Rostislav Večeřa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/1/212 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BENEFICIAL EFFECTS OF SILYMARIN AGAINST NEPHROTOXICITY CAUSED BY SOME CHEMICALS
by: V. Ivanov, et al.
Published: (2021-06-01) -
Effects of fenofibrate in patients with type 2 diabetes mellitus complicated by diabetic neuropathy
by: Olga Nikolaevna Tkacheva, et al.
Published: (2010-03-01) -
The Effectiveness and Safety of Fenofibrate and Saroglitazar in the Treatment of Diabetic Dyslipidemia
by: Bakhtawar Farooq, et al.
Published: (2024-05-01) -
Therapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload
by: adel abd elhaleim hagag
Published: (2014-08-01) -
Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia
by: Hansoo Kim, et al.
Published: (2024-11-01)